» Articles » PMID: 6095307

Serological Cross-reactivity Between Envelope Gene Products of Type I and Type II Human T-cell Leukemia Virus

Overview
Specialty Science
Date 1984 Dec 1
PMID 6095307
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

People exposed to type I human T-cell leukemia virus (HTLV-I) develop antibodies to an antigen at the surface of virus-infected cells, designated human T-cell leukemia virus membrane antigen (HTLV-MA). In an earlier study, we demonstrated that the major component of HTLV-MA is gp61, a glycoprotein encoded by the HTLV env gene. In the current study, we found that human antibodies that react with HTLV-MA on cells infected with HTLV-I react equally well with HTLV-MA on C3-44/MO, a target cell infected with type II HTLV. A glycoprotein with an approximate size of 67 kDa, gp67, was identified in C3-44/MO using immunoprecipitation and NaDodSO4/PAGE analysis. The positions of serine and cysteine residues were determined in the amino terminus of gp67 by radiolabel sequencing analysis. Comparison with the amino acid sequence deduced from the primary nucleotide sequence of HTLV-IIMO virus reveals that gp67 is also encoded, at least in part, by the env gene. The gp67 of HTLV-IIMO, like the env gene product of HTLV-ICR, gp61, is recognized both by antibodies from a HTLV-IIMO-infected patient with a variant form of hairy cell leukemia, and by antibodies from patients with HTLV-I-associated adult T-cell leukemia/lymphoma. These results indicate that, despite the divergence between HTLV-I and HTLV-II, the major env gene products of the two types of HTLV are conserved to the degree that they are serologically cross-reactive.

Citing Articles

Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.

Kannian P, Fernandez S, Jones K, Green P J Virol. 2013; 87(16):9344-52.

PMID: 23785214 PMC: 3754058. DOI: 10.1128/JVI.01079-13.


Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Haynes 2nd R, Phipps A, Yamamoto B, Green P, Lairmore M Viral Immunol. 2009; 22(6):397-405.

PMID: 19951176 PMC: 2852241. DOI: 10.1089/vim.2009.0059.


Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Tarsis S, Yu M, Parks E, Persaud D, Munoz J, Parks W J Virol. 1998; 72(1):841-6.

PMID: 9420297 PMC: 109446. DOI: 10.1128/JVI.72.1.841-846.1998.


Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.

Chang K, Wang L, Gao C, Alexander S, TING R, Bodner A Eur J Epidemiol. 1988; 4(4):426-34.

PMID: 2904886 DOI: 10.1007/BF00146393.


Rat lymphoid cell lines with HTLV-I production. III. Transmission of HTLV-I into rats and analysis of cell surface antigens associated with HTLV-I.

Yoshiki T, Kondo N, Chubachi T, Tateno M, Togashi T, Itoh T Arch Virol. 1987; 97(3-4):181-96.

PMID: 2892480 DOI: 10.1007/BF01314420.


References
1.
Maxam A, Gilbert W . A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977; 74(2):560-4. PMC: 392330. DOI: 10.1073/pnas.74.2.560. View

2.
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H . Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977; 50(3):481-92. View

3.
Gazdar A, Carney D, Bunn P, RUSSELL E, Jaffe E, Schechter G . Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980; 55(3):409-17. View

4.
Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. PMC: 350514. DOI: 10.1073/pnas.77.12.7415. View

5.
Reitz Jr M, Poiesz B, Ruscetti F, Gallo R . Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes. Proc Natl Acad Sci U S A. 1981; 78(3):1887-91. PMC: 319240. DOI: 10.1073/pnas.78.3.1887. View